StrideBio
is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders... Read moreStrideBio
is a North Carolina-based biotechnology firm that develops and commercializes gene therapies for the treatment of CNS and cardiovascular disorders... Read more
News
Apr 11, 2023
BioPharma-Reporter
StrideBio: Ginkgo touts gene therapy one-stop shop capabilities following acquisition
Apr 06, 2023
The Business Journals: Boston
StrideBio: Ginkgo Bioworks buys North Carolina startup's gene therapy platform
Feb 14, 2022
dergel media
StrideBio: StrideBio, Inc. [RESEARCH TRIANGLE PARK, NC] announced the appointment of Mark Velleca as Chief Executive Officer.
Oct 05, 2021
The Business Journals: Raleigh/Durham
StrideBio: Gene therapy firm expands operations in RTP as headcount reaches 100
Oct 04, 2021
MarketScreener
StrideBio: StrideBio Announces Achievement of Significant Operational Milestones Supporting Transition of Novel Gene Therapy Pipeline to Clinical Stage
Oct 04, 2021
WRAL TechWire
StrideBio: StrideBio expands its campus, plans to expand workforce over next 12 months
Jun 15, 2021
MarketScreener
StrideBio: StrideBio Expands Leadership Team with Accomplished Industry Executives
Apr 14, 2021
WRAL TechWire
StrideBio: Gene therapy startup StrideBio signs collaboration deal with Duke University
Apr 14, 2021
Business Wire
Press Release: StrideBio : StrideBio Announces a Multi-technology License and Master SRA with Duke University to Advance Next-generation Gene Therapies
Apr 08, 2020
Pharmafile
StrideBio, Inc: Dr Maritza McIntyre appointed Chief Development Officer at StrideBio
StrideBio Competitors
1
2
3
4
5
6